EPOGEN (Amgen Inc)
Welcome to the PulseAid listing for the EPOGEN drug offered from Amgen Inc. This Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | epoetin alfa |
| SUBSTANCE NAME: | ERYTHROPOIETIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1989-06-30 |
| END MARKETING DATE: | 0000-00-00 |
EPOGEN HUMAN PRESCRIPTION DRUG Details:
| Item Description | EPOGEN from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2000([iU]/mL) |
| START MARKETING DATE: | 1989-06-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-126_9fd139a6-efe9-4387-86bd-db3e6626ac80 |
| PRODUCT NDC: | 55513-126 |
| APPLICATION NUMBER: | BLA103234 |
Other ERYTHROPOIETIN Pharmaceutical Manufacturers / Labelers:
